The use of microbiological surveys to evaluate the co-regulation of abattoirs in New South Wales,Australia

In order to develop a microbiological baseline of meat produced for domestic consumption in the state of New South Wales, chilled carcases were sampled from 16 abattoirs. Aerobic Plate Counts (APCs) and Escherichia coli counts were obtained from samples taken by sponging sites specified for each species in the Microbiological Guidelines to the Australian meat standard. On beef carcases the mean log₁₀ APC/cm² was 2.21 and E. coli was detected on 25% of carcases (mean log positives ?0.61/cm²). For sheep carcases corresponding values were 2.4, 53% and log₁₀ -0.06/cm², respectively. For pig carcases values were 2.81, 63% and log₁₀ -0.23/cm², respectively. For skin-off goat carcases values were 1.15, 27% and log₁₀ -0.38/cm², respectively. In the present survey, levels of indicator bacteria on carcases processed via the co-regulatory system operated in Australia were similar to those established in surveys of abattoirs that operate the traditional system overseen by government inspectors.     

Temperature dependence of the 1.06-microm stimulated emission cross section of neodymium in YAG and in GSGG

A linear temperature dependence between -70 degrees C and +70 degrees C is reported for the peak stimulated emission cross section of Nd3+ ions in both yttrium aluminum garnet (YAG) and gadolinium scandium gallium garnet (GSGG).     

Removing edges from hypercubes to obtain vertex‐symmetric networks with small diameter

The binary hypercube Q _n has a small diameter, but a relatively large number of links. Because of this, efforts have been made to determine the maximum number of links that can be deleted without increasing the diameter. However, the resulting networks are not vertex‐symmetric. We propose a family of vertex‐symmetric spanning subnetworks of Q _n , whose diameter differs from that of Q _n by only a small constant factor. When n=2^k, the cube‐connected cycles network of dimension n is a vertex‐symmetric spanning subnetwork of Q _{n+lg n} . By selectively adding hypercube links, we obtain a degree 6 vertex‐symmetric network with diameter 3n/2. We also introduce a vertex‐symmetric spanning subnetwork of Q _n−1 with degree log₂ n, diameter 3n/2−2, log₂ n‐connectivity and maximal fault tolerance. This network hosts Q _n−1 with dilation 2(log₂ n)−1. This revised version was published online in June 2006 with corrections to the Cover Date.     

End-of-life decision-making in the hospital: current practice and future prospects

The contributions of the various ulnar-innervated muscles of the hand to the hypothenar compound muscle action potential (CMAP) were estimated by directly stimulating individual muscles and by analyzing CMAP shape changes resulting from manipulations that changed individual muscle lengths. The results show that the first peak of the negative phase of the hypothenar CMAP comes from the hypothenar muscles, but that the second peak is due to a large volume-conducted potential from the interosseous muscles. The interosseous contribution affects both the amplitude and the area of the CMAP, and makes these parameters sensitive to changes in the configuration of the fingers and the temperature gradient in the hand. To reduce the interosseous contribution, a "balanced reference" consisting of two reference electrodes, one over each tendon, is proposed.     

Large modulation depth, single-moded quantum well waveguide modulator operating around 1.57 mu m

The performance of long wavelength single-mode waveguide modulators suitable for monolithic integration with a quantum well laser is reported. The device operated between 1.560 mu m and 1.570 mu m. The guiding layer was formed by a 0.27 mu m quaternary layer at the centre of which were four 50 AA In/sub 0.53/Ga/sub 0.47/As quantum wells separated by 100 AA InP barrier layers. Lateral confinement was obtained by etching ridges in the top InP contact layer. For devices of 500 mu m length, a modulation depth of 19 dB was obtained at a wavelength of 1.568 mu m with a reverse bias voltage of only 3 V and an internal loss of 2.5 dB.<>     

Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice

We examined whether IL-2 regulates alloimmune responses by studying allograft survival in wild-type (IL-2+/+) and IL-2 gene-knockout (IL-2-/-) mice. The acute rejection of vascularized, cardiac allografts and the generation of allospecific CTLs were not impaired in the absence of IL-2. In contrast, blocking the B7-CD28 T cell costimulation pathway with CTLA4Ig induced long-term allograft survival (> 100 days) in IL-2+/+ recipients but failed to do so in IL-2-/- mice or in wild-type mice that had been treated with IL-2-neutralizing Ab around the time of transplantation. Allografts rejected by IL-2-/- recipients exhibited extensive mononuclear cell infiltrates despite CTLA4Ig administration. In vivo allostimulation in the absence of IL-2 led to exaggerated T lymphocyte proliferation and impaired apoptosis of activated T cells in untreated and CTLA4Ig-treated mice. These findings indicate that endogenous IL-2 is required for the induction of long-term allograft survival, and that IL-2 regulates alloimmune responses by preparing activated T lymphocytes for alloantigen-induced apoptosis.     

Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

The murine gamma-herpesvirus 68 has many similarities to EBV, and induces a syndrome comparable to infectious mononucleosis (IM). The frequency of activated CD8+ T cells (CD62L(lo)) in the peripheral blood increased greater than fourfold by 21 d after infection of C57BL/6J (H-2(b)) mice, and remained high for at least a further month. The spectrum of T cell receptor usage was greatly skewed, with as many as 75% of the CD8+ T cells in the blood expressing a Vbeta4+ phenotype. Interestingly, the Vbeta4 dominance was also seen, to varying extents, in H-2(k), H-2(d), H-2(u), and H-2(q) strains of mice. In addition, although CD4 depletion from day 11 had no effect on the Vbeta4 bias of the T cells, the Vbeta4+CD8+ expansion was absent in H-2IA(b)-deficient congenic mice. However, the numbers of cycling cells in the CD4 antibody-depleted mice and mice that are CD4 deficient as a consequence of the deletion of MHC class II, were generally lower. The findings suggest that the IM-like disease is driven both by cytokines provided by CD4+ T cells and by a viral superantigen presented by MHC class II glycoproteins to Vbeta4+CD8+ T cells.     

Influence of verapamil and digoxin on the in vitro binding of doxorubicin to the rat heart

A study has been carried out to characterize the binding of doxorubicin to heart homogenates and subcellular fractions. The technique chosen to perform the study was equilibrium dialysis and the levels of anthracycline in the samples obtained from the dialysis were assessed using HPLC. Doxorubicin has high affinity to heart homogenates and subcellular fractions such as nuclear, mitochondrial and microsomal. The binding was saturable and dose-dependent. Doxorubicin binding is decreased in the presence of digoxin and especially verapamil.     

Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate

BACKGROUND AND OBJECTIVE: Intensive induction and post-remission therapies have improved the prognosis in adult acute lymphoblastic leukemia (ALL). However, different from children, the impact of late intensification therapy in the overall results of treatment has not been consistently evaluated. The objective of this study was to analyze the results of a multicenter prospective protocol, PETHEMA ALL-89, in which, after intensive induction and consolidation therapy, randomization to receive delayed intensification treatment was performed. DESIGN AND METHODS: One hundred and eight adults (age > or = 15 years) diagnosed with ALL (ALL L3 excluded) in 22 Spanish hospitals from 1989 to 1994 were treated with a five-drug induction therapy, followed by four cycles of early post-remission treatment during four months, and maintenance therapy for two years. Patients in remission at the end of the first year were randomized to receive one six-week cycle of late intensification therapy. Uni- and multivariate analyses of early response to treatment, complete remission (CR), leukemia-free survival (LFS) and overall survival (OS) were performed. RESULTS: The median (range) age of the series was 28 (15-74) years and leukocyte count 26 x 10(9)/L (1-600). ALL L1/L2 was present in 38/70 patients, early pre-B in 13, common in 53, pre-B in 12 and T in 30 cases. The CR rate was 86%, and refractory disease 9%. Median LFS was 34 months, with a 5-yr probability of 41% (95% CI, 29-53), whereas median OS was 51 months and 5-year probability 47% (34-59%). There were no differences in either LFS and OS between patients who did or did not receive delayed intensification therapy. Prognostic factors for CR attainment were advanced age and slow response to therapy. These two features were, in addition to high leukocyte counts, the parameters with negative influence in both LFS and OS. INTERPRETATION AND CONCLUSIONS: The results of PETHEMA ALL-89 are similar to those referred in other chemotherapy-based protocols in adult ALL. Delayed intensification has not improved the length of remission and survival. Efforts to improve the prognosis of adult ALL patients must be mainly focused in early intensification treatment.